世界のプロスタグランジンI2市場予測 2023年-2029年

【英語タイトル】Global Prostaglandin I2 Market Growth 2023-2029

LP Informationが出版した調査資料(LP23DC11566)・商品コード:LP23DC11566
・発行会社(調査会社):LP Information
・発行日:2023年11月
・ページ数:93
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のプロスタグランジンI2市場」は、過去の販売実績から2022年の世界のプロスタグランジンI2の総販売量を検討し、2023年から2029年の予測されるプロスタグランジンI2の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のプロスタグランジンI2の市場規模を掲載し、XXX百万米ドル規模の世界のプロスタグランジンI2市場の詳細な分析を提供します。本インサイトレポートは、世界のプロスタグランジンI2業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のプロスタグランジンI2市場における各社の独自のポジションをより深く理解するために、プロスタグランジンI2製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のプロスタグランジンI2市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。プロスタグランジンI2の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。プロスタグランジンI2の中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。プロスタグランジンI2のヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

プロスタグランジンI2の世界主要メーカーとしては、United Therapeutics、 J & J、 GSK、 Teva、 Toray、 Tide Pharma、 Bayer AGなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のプロスタグランジンI2市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではプロスタグランジンI2市場をセグメンテーションし、種類別 (エポプロステノールナトリウム、トレプロスチニル、イロプロスト、ベラプロストナトリウム)、用途別 (注射、経口、吸入)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:エポプロステノールナトリウム、トレプロスチニル、イロプロスト、ベラプロストナトリウム

・用途別区分:注射、経口、吸入

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界のプロスタグランジンI2市場の10年間の市場状況・展望は?
・世界および地域別に見たプロスタグランジンI2市場成長の要因は何か?
・プロスタグランジンI2の市場機会はエンドマーケットの規模によってどのように変化するのか?
・プロスタグランジンI2のタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:プロスタグランジンI2の年間販売量2018-2029、地域別現状・将来分析
・プロスタグランジンI2の種類別セグメント:エポプロステノールナトリウム、トレプロスチニル、イロプロスト、ベラプロストナトリウム
・プロスタグランジンI2の種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・プロスタグランジンI2の用途別セグメント:注射、経口、吸入
・プロスタグランジンI2の用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のプロスタグランジンI2市場
・企業別のグローバルプロスタグランジンI2市場データ:2018-2023年の年間販売量、市場シェア
・企業別のプロスタグランジンI2の年間売上:2018-2023年の売上、市場シェア
・企業別のプロスタグランジンI2販売価格
・主要企業のプロスタグランジンI2生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

プロスタグランジンI2の地域別レビュー
・地域別のプロスタグランジンI2市場規模2018-2023:年間販売量、売上
・主要国別のプロスタグランジンI2市場規模2018-2023:年間販売量、売上
・南北アメリカのプロスタグランジンI2販売の成長
・アジア太平洋のプロスタグランジンI2販売の成長
・ヨーロッパのプロスタグランジンI2販売の成長
・中東・アフリカのプロスタグランジンI2販売の成長

南北アメリカ市場
・南北アメリカの国別のプロスタグランジンI2販売量、売上(2018-2023)
・南北アメリカのプロスタグランジンI2の種類別販売量
・南北アメリカのプロスタグランジンI2の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のプロスタグランジンI2販売量、売上(2018-2023)
・アジア太平洋のプロスタグランジンI2の種類別販売量
・アジア太平洋のプロスタグランジンI2の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のプロスタグランジンI2販売量、売上(2018-2023)
・ヨーロッパのプロスタグランジンI2の種類別販売量
・ヨーロッパのプロスタグランジンI2の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のプロスタグランジンI2販売量、売上(2018-2023)
・中東・アフリカのプロスタグランジンI2の種類別販売量
・中東・アフリカのプロスタグランジンI2の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・プロスタグランジンI2の製造コスト構造分析
・プロスタグランジンI2の製造プロセス分析
・プロスタグランジンI2の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・プロスタグランジンI2の主要なグローバル販売業者
・プロスタグランジンI2の主要なグローバル顧客

地域別のプロスタグランジンI2市場予測レビュー
・地域別のプロスタグランジンI2市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・プロスタグランジンI2の種類別市場規模予測
・プロスタグランジンI2の用途別市場規模予測

主要企業分析
United Therapeutics、 J & J、 GSK、 Teva、 Toray、 Tide Pharma、 Bayer AG
・企業情報
・プロスタグランジンI2製品
・プロスタグランジンI2販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

The global Prostaglandin I2 market size is projected to grow from US$ 2403.6 million in 2022 to US$ 3743.8 million in 2029; it is expected to grow at a CAGR of 6.5% from 2023 to 2029.
United States market for Prostaglandin I2 is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Prostaglandin I2 is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Prostaglandin I2 is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Prostaglandin I2 players cover United Therapeutics, J & J, GSK, Teva, Toray, Tide Pharma and Bayer AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Prostaglandin I2 (PGI), or prostacyclin, is one of the prostanoids, a group of local hormones that are best known for their roles in mediating inflammation.
LPI (LP Information)’ newest research report, the “Prostaglandin I2 Industry Forecast” looks at past sales and reviews total world Prostaglandin I2 sales in 2022, providing a comprehensive analysis by region and market sector of projected Prostaglandin I2 sales for 2023 through 2029. With Prostaglandin I2 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prostaglandin I2 industry.
This Insight Report provides a comprehensive analysis of the global Prostaglandin I2 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prostaglandin I2 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prostaglandin I2 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prostaglandin I2 and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prostaglandin I2.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostaglandin I2 market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Segmentation by application
For Injection
For Oral
For Inhalation
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
United Therapeutics
J & J
GSK
Teva
Toray
Tide Pharma
Bayer AG
Key Questions Addressed in this Report
What is the 10-year outlook for the global Prostaglandin I2 market?
What factors are driving Prostaglandin I2 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Prostaglandin I2 market opportunities vary by end market size?
How does Prostaglandin I2 break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prostaglandin I2 Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Prostaglandin I2 by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Prostaglandin I2 by Country/Region, 2018, 2022 & 2029
2.2 Prostaglandin I2 Segment by Type
2.2.1 Epoprostenol Sodium
2.2.2 Treprostinil
2.2.3 Iloprost
2.2.4 Beraprost Sodium
2.3 Prostaglandin I2 Sales by Type
2.3.1 Global Prostaglandin I2 Sales Market Share by Type (2018-2023)
2.3.2 Global Prostaglandin I2 Revenue and Market Share by Type (2018-2023)
2.3.3 Global Prostaglandin I2 Sale Price by Type (2018-2023)
2.4 Prostaglandin I2 Segment by Application
2.4.1 For Injection
2.4.2 For Oral
2.4.3 For Inhalation
2.5 Prostaglandin I2 Sales by Application
2.5.1 Global Prostaglandin I2 Sale Market Share by Application (2018-2023)
2.5.2 Global Prostaglandin I2 Revenue and Market Share by Application (2018-2023)
2.5.3 Global Prostaglandin I2 Sale Price by Application (2018-2023)
3 Global Prostaglandin I2 by Company
3.1 Global Prostaglandin I2 Breakdown Data by Company
3.1.1 Global Prostaglandin I2 Annual Sales by Company (2018-2023)
3.1.2 Global Prostaglandin I2 Sales Market Share by Company (2018-2023)
3.2 Global Prostaglandin I2 Annual Revenue by Company (2018-2023)
3.2.1 Global Prostaglandin I2 Revenue by Company (2018-2023)
3.2.2 Global Prostaglandin I2 Revenue Market Share by Company (2018-2023)
3.3 Global Prostaglandin I2 Sale Price by Company
3.4 Key Manufacturers Prostaglandin I2 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prostaglandin I2 Product Location Distribution
3.4.2 Players Prostaglandin I2 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Prostaglandin I2 by Geographic Region
4.1 World Historic Prostaglandin I2 Market Size by Geographic Region (2018-2023)
4.1.1 Global Prostaglandin I2 Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Prostaglandin I2 Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Prostaglandin I2 Market Size by Country/Region (2018-2023)
4.2.1 Global Prostaglandin I2 Annual Sales by Country/Region (2018-2023)
4.2.2 Global Prostaglandin I2 Annual Revenue by Country/Region (2018-2023)
4.3 Americas Prostaglandin I2 Sales Growth
4.4 APAC Prostaglandin I2 Sales Growth
4.5 Europe Prostaglandin I2 Sales Growth
4.6 Middle East & Africa Prostaglandin I2 Sales Growth
5 Americas
5.1 Americas Prostaglandin I2 Sales by Country
5.1.1 Americas Prostaglandin I2 Sales by Country (2018-2023)
5.1.2 Americas Prostaglandin I2 Revenue by Country (2018-2023)
5.2 Americas Prostaglandin I2 Sales by Type
5.3 Americas Prostaglandin I2 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostaglandin I2 Sales by Region
6.1.1 APAC Prostaglandin I2 Sales by Region (2018-2023)
6.1.2 APAC Prostaglandin I2 Revenue by Region (2018-2023)
6.2 APAC Prostaglandin I2 Sales by Type
6.3 APAC Prostaglandin I2 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Prostaglandin I2 by Country
7.1.1 Europe Prostaglandin I2 Sales by Country (2018-2023)
7.1.2 Europe Prostaglandin I2 Revenue by Country (2018-2023)
7.2 Europe Prostaglandin I2 Sales by Type
7.3 Europe Prostaglandin I2 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prostaglandin I2 by Country
8.1.1 Middle East & Africa Prostaglandin I2 Sales by Country (2018-2023)
8.1.2 Middle East & Africa Prostaglandin I2 Revenue by Country (2018-2023)
8.2 Middle East & Africa Prostaglandin I2 Sales by Type
8.3 Middle East & Africa Prostaglandin I2 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prostaglandin I2
10.3 Manufacturing Process Analysis of Prostaglandin I2
10.4 Industry Chain Structure of Prostaglandin I2
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Prostaglandin I2 Distributors
11.3 Prostaglandin I2 Customer
12 World Forecast Review for Prostaglandin I2 by Geographic Region
12.1 Global Prostaglandin I2 Market Size Forecast by Region
12.1.1 Global Prostaglandin I2 Forecast by Region (2024-2029)
12.1.2 Global Prostaglandin I2 Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Prostaglandin I2 Forecast by Type
12.7 Global Prostaglandin I2 Forecast by Application
13 Key Players Analysis
13.1 United Therapeutics
13.1.1 United Therapeutics Company Information
13.1.2 United Therapeutics Prostaglandin I2 Product Portfolios and Specifications
13.1.3 United Therapeutics Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 United Therapeutics Main Business Overview
13.1.5 United Therapeutics Latest Developments
13.2 J & J
13.2.1 J & J Company Information
13.2.2 J & J Prostaglandin I2 Product Portfolios and Specifications
13.2.3 J & J Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 J & J Main Business Overview
13.2.5 J & J Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Prostaglandin I2 Product Portfolios and Specifications
13.3.3 GSK Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Teva
13.4.1 Teva Company Information
13.4.2 Teva Prostaglandin I2 Product Portfolios and Specifications
13.4.3 Teva Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Teva Main Business Overview
13.4.5 Teva Latest Developments
13.5 Toray
13.5.1 Toray Company Information
13.5.2 Toray Prostaglandin I2 Product Portfolios and Specifications
13.5.3 Toray Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Toray Main Business Overview
13.5.5 Toray Latest Developments
13.6 Tide Pharma
13.6.1 Tide Pharma Company Information
13.6.2 Tide Pharma Prostaglandin I2 Product Portfolios and Specifications
13.6.3 Tide Pharma Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Tide Pharma Main Business Overview
13.6.5 Tide Pharma Latest Developments
13.7 Bayer AG
13.7.1 Bayer AG Company Information
13.7.2 Bayer AG Prostaglandin I2 Product Portfolios and Specifications
13.7.3 Bayer AG Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bayer AG Main Business Overview
13.7.5 Bayer AG Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Prostaglandin I2 Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Prostaglandin I2 Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Epoprostenol Sodium
Table 4. Major Players of Treprostinil
Table 5. Major Players of Iloprost
Table 6. Major Players of Beraprost Sodium
Table 7. Global Prostaglandin I2 Sales by Type (2018-2023) & (K Units)
Table 8. Global Prostaglandin I2 Sales Market Share by Type (2018-2023)
Table 9. Global Prostaglandin I2 Revenue by Type (2018-2023) & ($ million)
Table 10. Global Prostaglandin I2 Revenue Market Share by Type (2018-2023)
Table 11. Global Prostaglandin I2 Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Prostaglandin I2 Sales by Application (2018-2023) & (K Units)
Table 13. Global Prostaglandin I2 Sales Market Share by Application (2018-2023)
Table 14. Global Prostaglandin I2 Revenue by Application (2018-2023)
Table 15. Global Prostaglandin I2 Revenue Market Share by Application (2018-2023)
Table 16. Global Prostaglandin I2 Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Prostaglandin I2 Sales by Company (2018-2023) & (K Units)
Table 18. Global Prostaglandin I2 Sales Market Share by Company (2018-2023)
Table 19. Global Prostaglandin I2 Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Prostaglandin I2 Revenue Market Share by Company (2018-2023)
Table 21. Global Prostaglandin I2 Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Prostaglandin I2 Producing Area Distribution and Sales Area
Table 23. Players Prostaglandin I2 Products Offered
Table 24. Prostaglandin I2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Prostaglandin I2 Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Prostaglandin I2 Sales Market Share Geographic Region (2018-2023)
Table 29. Global Prostaglandin I2 Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Prostaglandin I2 Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Prostaglandin I2 Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Prostaglandin I2 Sales Market Share by Country/Region (2018-2023)
Table 33. Global Prostaglandin I2 Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Prostaglandin I2 Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Prostaglandin I2 Sales by Country (2018-2023) & (K Units)
Table 36. Americas Prostaglandin I2 Sales Market Share by Country (2018-2023)
Table 37. Americas Prostaglandin I2 Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Prostaglandin I2 Revenue Market Share by Country (2018-2023)
Table 39. Americas Prostaglandin I2 Sales by Type (2018-2023) & (K Units)
Table 40. Americas Prostaglandin I2 Sales by Application (2018-2023) & (K Units)
Table 41. APAC Prostaglandin I2 Sales by Region (2018-2023) & (K Units)
Table 42. APAC Prostaglandin I2 Sales Market Share by Region (2018-2023)
Table 43. APAC Prostaglandin I2 Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Prostaglandin I2 Revenue Market Share by Region (2018-2023)
Table 45. APAC Prostaglandin I2 Sales by Type (2018-2023) & (K Units)
Table 46. APAC Prostaglandin I2 Sales by Application (2018-2023) & (K Units)
Table 47. Europe Prostaglandin I2 Sales by Country (2018-2023) & (K Units)
Table 48. Europe Prostaglandin I2 Sales Market Share by Country (2018-2023)
Table 49. Europe Prostaglandin I2 Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Prostaglandin I2 Revenue Market Share by Country (2018-2023)
Table 51. Europe Prostaglandin I2 Sales by Type (2018-2023) & (K Units)
Table 52. Europe Prostaglandin I2 Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Prostaglandin I2 Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Prostaglandin I2 Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Prostaglandin I2 Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Prostaglandin I2 Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Prostaglandin I2 Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Prostaglandin I2 Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Prostaglandin I2
Table 60. Key Market Challenges & Risks of Prostaglandin I2
Table 61. Key Industry Trends of Prostaglandin I2
Table 62. Prostaglandin I2 Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Prostaglandin I2 Distributors List
Table 65. Prostaglandin I2 Customer List
Table 66. Global Prostaglandin I2 Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Prostaglandin I2 Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Prostaglandin I2 Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Prostaglandin I2 Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Prostaglandin I2 Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Prostaglandin I2 Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Prostaglandin I2 Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Prostaglandin I2 Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Prostaglandin I2 Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Prostaglandin I2 Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Prostaglandin I2 Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Prostaglandin I2 Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Prostaglandin I2 Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Prostaglandin I2 Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. United Therapeutics Basic Information, Prostaglandin I2 Manufacturing Base, Sales Area and Its Competitors
Table 81. United Therapeutics Prostaglandin I2 Product Portfolios and Specifications
Table 82. United Therapeutics Prostaglandin I2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. United Therapeutics Main Business
Table 84. United Therapeutics Latest Developments
Table 85. J & J Basic Information, Prostaglandin I2 Manufacturing Base, Sales Area and Its Competitors
Table 86. J & J Prostaglandin I2 Product Portfolios and Specifications
Table 87. J & J Prostaglandin I2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. J & J Main Business
Table 89. J & J Latest Developments
Table 90. GSK Basic Information, Prostaglandin I2 Manufacturing Base, Sales Area and Its Competitors
Table 91. GSK Prostaglandin I2 Product Portfolios and Specifications
Table 92. GSK Prostaglandin I2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. GSK Main Business
Table 94. GSK Latest Developments
Table 95. Teva Basic Information, Prostaglandin I2 Manufacturing Base, Sales Area and Its Competitors
Table 96. Teva Prostaglandin I2 Product Portfolios and Specifications
Table 97. Teva Prostaglandin I2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Teva Main Business
Table 99. Teva Latest Developments
Table 100. Toray Basic Information, Prostaglandin I2 Manufacturing Base, Sales Area and Its Competitors
Table 101. Toray Prostaglandin I2 Product Portfolios and Specifications
Table 102. Toray Prostaglandin I2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Toray Main Business
Table 104. Toray Latest Developments
Table 105. Tide Pharma Basic Information, Prostaglandin I2 Manufacturing Base, Sales Area and Its Competitors
Table 106. Tide Pharma Prostaglandin I2 Product Portfolios and Specifications
Table 107. Tide Pharma Prostaglandin I2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Tide Pharma Main Business
Table 109. Tide Pharma Latest Developments
Table 110. Bayer AG Basic Information, Prostaglandin I2 Manufacturing Base, Sales Area and Its Competitors
Table 111. Bayer AG Prostaglandin I2 Product Portfolios and Specifications
Table 112. Bayer AG Prostaglandin I2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Bayer AG Main Business
Table 114. Bayer AG Latest Developments
List of Figures
Figure 1. Picture of Prostaglandin I2
Figure 2. Prostaglandin I2 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prostaglandin I2 Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Prostaglandin I2 Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Prostaglandin I2 Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Epoprostenol Sodium
Figure 10. Product Picture of Treprostinil
Figure 11. Product Picture of Iloprost
Figure 12. Product Picture of Beraprost Sodium
Figure 13. Global Prostaglandin I2 Sales Market Share by Type in 2022
Figure 14. Global Prostaglandin I2 Revenue Market Share by Type (2018-2023)
Figure 15. Prostaglandin I2 Consumed in For Injection
Figure 16. Global Prostaglandin I2 Market: For Injection (2018-2023) & (K Units)
Figure 17. Prostaglandin I2 Consumed in For Oral
Figure 18. Global Prostaglandin I2 Market: For Oral (2018-2023) & (K Units)
Figure 19. Prostaglandin I2 Consumed in For Inhalation
Figure 20. Global Prostaglandin I2 Market: For Inhalation (2018-2023) & (K Units)
Figure 21. Global Prostaglandin I2 Sales Market Share by Application (2022)
Figure 22. Global Prostaglandin I2 Revenue Market Share by Application in 2022
Figure 23. Prostaglandin I2 Sales Market by Company in 2022 (K Units)
Figure 24. Global Prostaglandin I2 Sales Market Share by Company in 2022
Figure 25. Prostaglandin I2 Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Prostaglandin I2 Revenue Market Share by Company in 2022
Figure 27. Global Prostaglandin I2 Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Prostaglandin I2 Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Prostaglandin I2 Sales 2018-2023 (K Units)
Figure 30. Americas Prostaglandin I2 Revenue 2018-2023 ($ Millions)
Figure 31. APAC Prostaglandin I2 Sales 2018-2023 (K Units)
Figure 32. APAC Prostaglandin I2 Revenue 2018-2023 ($ Millions)
Figure 33. Europe Prostaglandin I2 Sales 2018-2023 (K Units)
Figure 34. Europe Prostaglandin I2 Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Prostaglandin I2 Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Prostaglandin I2 Revenue 2018-2023 ($ Millions)
Figure 37. Americas Prostaglandin I2 Sales Market Share by Country in 2022
Figure 38. Americas Prostaglandin I2 Revenue Market Share by Country in 2022
Figure 39. Americas Prostaglandin I2 Sales Market Share by Type (2018-2023)
Figure 40. Americas Prostaglandin I2 Sales Market Share by Application (2018-2023)
Figure 41. United States Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Prostaglandin I2 Sales Market Share by Region in 2022
Figure 46. APAC Prostaglandin I2 Revenue Market Share by Regions in 2022
Figure 47. APAC Prostaglandin I2 Sales Market Share by Type (2018-2023)
Figure 48. APAC Prostaglandin I2 Sales Market Share by Application (2018-2023)
Figure 49. China Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Prostaglandin I2 Sales Market Share by Country in 2022
Figure 57. Europe Prostaglandin I2 Revenue Market Share by Country in 2022
Figure 58. Europe Prostaglandin I2 Sales Market Share by Type (2018-2023)
Figure 59. Europe Prostaglandin I2 Sales Market Share by Application (2018-2023)
Figure 60. Germany Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Prostaglandin I2 Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Prostaglandin I2 Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Prostaglandin I2 Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Prostaglandin I2 Sales Market Share by Application (2018-2023)
Figure 69. Egypt Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Prostaglandin I2 Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Prostaglandin I2 in 2022
Figure 75. Manufacturing Process Analysis of Prostaglandin I2
Figure 76. Industry Chain Structure of Prostaglandin I2
Figure 77. Channels of Distribution
Figure 78. Global Prostaglandin I2 Sales Market Forecast by Region (2024-2029)
Figure 79. Global Prostaglandin I2 Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Prostaglandin I2 Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Prostaglandin I2 Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Prostaglandin I2 Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Prostaglandin I2 Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のプロスタグランジンI2市場予測 2023年-2029年] (コード:LP23DC11566)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のプロスタグランジンI2市場予測 2023年-2029年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆